Please login to the form below
Protein Sciences
This page shows the latest Protein Sciences news and features for those working in and with pharma, biotech and healthcare.
Sanofi to pay $750m for vaccines biotech Protein Sciences
Manon M.J. Cox, Protein Sciences’ president and CEO, added: "Protein Sciences was actively looking for an opportunity to grow its business, particularly in the US. ... Its deal with Protein Sciences follows unsuccessful bids in the last year for
Latest news
-
Budget deal brings FDA back to life
Advisory committee meetings continued and there were a few new product approvals and alerts, although there are reports of delays for some products including a flu vaccine made by Protein Sciences.
-
FDA approves first egg-free flu vaccine Flublok
production. Instead, the vaccine, which was developed by Protein Sciences in partnership with the US Department of Health and Human Services, is produced using an insect virus (baculovirus). ... Protein Sciences is also developing Panblok in partnership
-
Early identification key for healthcare
The meeting also heard about the growing antibodies market. Lotta Ljungqvist, head of R&D BioTechnologies, Life Sciences at GE Healthcare Sweden, said: "There will be more protein-based drugs available ... The region has already attracted AstraZeneca, GE
More from news
Approximately 2 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2015
Regaining of rights. 564. Alpine Immune Sciences/ Kite Pharma. 2 transmembrane immunomodulatory protein (TIP) programmes (discovery). ... Collaboration - R&D. 126. †† Genexine/ Tasgen Bio-Tech. 3 clinical and 2 preclinical therapeutic protein/
-
Deal Watch table for July 2013
172. Nerviano Medical Sciences / Servier . Collaboration, licence, option. Protein kinase TTK/MPS1 inhibitors (preclinical).
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
F-star appoints vice president of protein sciences
Mike Davies joins from CPI Biologics. Vienna-headquartered biopharmaceutical company F-star has appointed Mike Davies as vice president of protein sciences at its Cambridge, UK research site. ... His strong experience in the development and
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Roche’s Polivy backed by FDA Advisory Committee for lymphoma therapy
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- LEO Pharma enters clinical trial partnership with ICON
- Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- UCB's bimekizumab shows continued improvement in hidradenitis suppurativa patients
- The Considered appoints Bam Zahraie as chief experience officer
- The impact of pharma congresses on HCPs – virtual and in person
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
- A relentless commitment to neuroscience
- Putting the ovation into innovation: trends from ESMO
- Sanofi to acquire Provention Bio in deal worth $2.9bn
- Neurodiversity and healthcare communications – do we know enough and do we do enough?
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
- WHY ARE PATIENT SUPPORT PROGRAMMES NOT WORKING?
- By offering patients knowledge, skills and confidence, they empower patients to be more actively involved in their health. Holistic support can help tackle adherence, mental health or anything else patients...
